Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies

SM Mantooth, Y Abdou, AR Saez-Ibañez… - Frontiers in …, 2024 - frontiersin.org
Breast cancer poses one of the largest threats to women's health. Treatment continues to
improve for all the subtypes of breast cancer, but some subtypes, such as triple negative …

Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells

A Kotsifaki, S Maroulaki, A Armakolas - International Journal of Molecular …, 2024 - mdpi.com
This review offers a comprehensive exploration of the intricate immunological landscape of
breast cancer (BC), focusing on recent advances in diagnosis and prognosis through the …

Genomic Features of Homologous Recombination Deficiency in Breast Cancer: Impact on Testing and Immunotherapy

U Ali, S Vungarala, V Tiriveedhi - Genes, 2024 - mdpi.com
Simple Summary Cancer is the second most common cause of death in the USA. Genomic
instability is one of the well-established hallmarks of cancer. The homologous recombination …

The Tumor Microenvironment and Immune Response in Breast Cancer

B Monzavi-Karbassi, T Kelly, SR Post - International Journal of Molecular …, 2024 - mdpi.com
The complex interactions between cancer cells and their surrounding microenvironment are
fundamental in determining tumor progression, response to therapy, and, ultimately, patient …

Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer

Y Li, S Yang, L Qi, Y Li, X Wang - Advances in Therapy, 2024 - Springer
Methods Differential gene expression analysis was conducted using the R software with
data from the Gene Expression Omnibus (GEO) database. Then, the identified differentially …